Aaron R. Hansen - Researcher Profile

Publications

2 shown

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness , Kevin J. Harrington , Richard Greil +97 more

2019 The Lancet 2928 citations

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle , Dung T. Le , Paolo A. Ascierto +19 more

PURPOSE Genomes of tumors that are deficient in DNA mismatch repair (dMMR) have high microsatellite instability (MSI-H) and harbor hundreds to thousands of somatic mutations tha...

2019 Journal of Clinical Oncology 2734 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,662
Institution: Princess Margaret Cancer Centre

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2363-8707

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.